Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Misbah Noshela Ghazanfar; Ewa Anna Bartko; Nicolai Skovbjerg Arildsen; Lars K. Poulsen; Bettina Margrethe Jensen; Christian Enevold; Jesper Grønlund Holm; Anders Woetmann; Niels Ødum; Simon Francis Thomsen

doi:10.1111/cea.14121

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Misbah Noshela Ghazanfar^*, Ewa Anna Bartko, Nicolai Skovbjerg Arildsen, Lars K. Poulsen, Bettina Margrethe Jensen, Christian Enevold, Jesper Grønlund Holm, Anders Woetmann, Niels Ødum, Simon Francis Thomsen

^*Corresponding author af dette arbejde

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Clinical and Experimental Allergy
Vol/bind	52
Udgave nummer	5
Sider (fra-til)	715-718
Antal sider	4
ISSN	0954-7894
DOI	https://doi.org/10.1111/cea.14121
Status	Udgivet - maj 2022

Adgang til dokumentet

10.1111/cea.14121

Andre filer og links

Link to publication in Scopus

Citationsformater

Ghazanfar, M. N., Bartko, E. A., Arildsen, N. S., Poulsen, L. K., Jensen, B. M., Enevold, C., Holm, J. G., Woetmann, A., Ødum, N., & Thomsen, S. F. (2022). Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study. Clinical and Experimental Allergy, 52(5), 715-718. https://doi.org/10.1111/cea.14121

@article{72e58e8c49724d059e7b650a679381cd,

title = "Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study",

keywords = "Anti-Allergic Agents/therapeutic use, Chronic Disease, Chronic Urticaria/drug therapy, Humans, Omalizumab/therapeutic use, Prospective Studies, Treatment Outcome, Urticaria/diagnosis",

author = "Ghazanfar, {Misbah Noshela} and Bartko, {Ewa Anna} and Arildsen, {Nicolai Skovbjerg} and Poulsen, {Lars K.} and Jensen, {Bettina Margrethe} and Christian Enevold and Holm, {Jesper Gr{\o}nlund} and Anders Woetmann and Niels {\O}dum and Thomsen, {Simon Francis}",

year = "2022",

month = may,

doi = "10.1111/cea.14121",

language = "English",

volume = "52",

pages = "715--718",

journal = "Clinical Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria

T2 - A three-month prospective study

AU - Ghazanfar, Misbah Noshela

AU - Bartko, Ewa Anna

AU - Arildsen, Nicolai Skovbjerg

AU - Poulsen, Lars K.

AU - Jensen, Bettina Margrethe

AU - Enevold, Christian

AU - Holm, Jesper Grønlund

AU - Woetmann, Anders

AU - Ødum, Niels

AU - Thomsen, Simon Francis

PY - 2022/5

Y1 - 2022/5

KW - Anti-Allergic Agents/therapeutic use

KW - Chronic Disease

KW - Chronic Urticaria/drug therapy

KW - Humans

KW - Omalizumab/therapeutic use

KW - Prospective Studies

KW - Treatment Outcome

KW - Urticaria/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85126838148&partnerID=8YFLogxK

U2 - 10.1111/cea.14121

DO - 10.1111/cea.14121

M3 - Letter

C2 - 35278253

AN - SCOPUS:85126838148

VL - 52

SP - 715

EP - 718

JO - Clinical Allergy

JF - Clinical Allergy

SN - 0954-7894

IS - 5

ER -